Table 5.
HR | 95% CI | p | |
---|---|---|---|
Sex | |||
Male * | 0.636 | 0.32–1.28 | 0.206 |
Female | |||
Histological type | |||
ADC * | 1.3 | 0.8–2.02 | 0.304 |
SSC | |||
ADC subtype | |||
Acinar * | 0.016 | ||
Papillary | 1.96 | 0.7–5.5 | 0.203 |
Solid | 4.2 | 1.6–11.4 | 0.004 |
Gradus | |||
1 * | 1.26 | 0.8–1.97 | 0.313 |
2 | |||
3 | |||
Lympho-vascular invasion | |||
No * | 2.15 | 1.17–3.98 | 0.015 |
Yes | |||
Pathological stage | |||
1 * | 1.33 | 0.94–1.9 | 0.108 |
2 | |||
3 | |||
Lymph node status | |||
Negative * | 1.4 | 0.79–2.5 | 0.241 |
Positive | |||
PD-L1 expression | |||
Negative * | 0.87 | 0.48–1.6 | 0.646 |
Positive | |||
IMR | |||
Absent + Low | 2 | 0.79–5 | 0.142 |
Strong * |
M—male; F—female; * level of reference IMR immune microenvironment response.